Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Hypoglycaemia Notification Device Hyposafe H02

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Informed consent obtained before any study related activities~* Type 1 diabetes diagnosed at least five years prior to inclusion in the study~* Impaired awareness and/or history of at least one severe hypoglycaemia within the preceding year~Exclusion Criteria:~* Severe cardiac disease~* History of stroke or cerebral haemorrhage and any other structural cerebral disease~* Active cancer or cancer diagnosis within the past 5 years~* Uraemia defined as s-creatinine ≥ 3 times upper reference value~* Liver disease defined as s-ALAT ≥ 3 times upper reference interval~* Epilepsy~* Use of antiepileptic drugs for any indication~* Clinically important hearing impairment~* Use of active implantable medical device including pacemaker and ICD-unit and cochlear implant~* Use of following drugs: Chemotherapeutic drugs of any kind, Methotrexate, Third generation antipsychotic drugs (aripiprazole, quetiapine, clozapine, ziprasidone, paliperidone, risperidone, sertindole, amisulpride, olanzapine)~* Contraindications to the local anaesthetic used during implantation~* Known or suspected abuse of alcohol or any other neuro-active substances~* Infection at the site of device implantation~* Any haemorrhagic disease~* Females of childbearing potential who are pregnant or intend to become pregnant or are not using adequate contraceptive methods throughout the study~* Performing extreme sport, including scuba diving (snorkel diving is allowed) or parachute jumping~* Incapable of understanding the subject information or unlikely to complete the study for any reason~* Operating MRI scanners~* Operating handheld transceivers for communication (e.g. within the police, medical, fire, air traffic control, marine or military)~* Working at broadcast stations for television or FM/DAB radio~* Use of CGM or FGM with visible glucose measurements and activated glucose notifications~* Involved in therapies with medical devices that deliver electrical energy into the area around the implant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- hyposafe H02 (Type: EXPERIMENTAL): All subjects included are assigned to hyposafe H02-testing

Based on this trial design, predict the completion outcome and termination type (if applicable).